CINECA IRIS Institutional Research Information System

LUCCHI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.181
AS - Asia 9.557
EU - Europa 6.981
SA - Sud America 1.488
Continente sconosciuto - Info sul continente non disponibili 497
AF - Africa 441
OC - Oceania 35
Totale 38.180
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.598
SG - Singapore 3.204
CN - Cina 2.418
IT - Italia 2.195
HK - Hong Kong 1.559
BR - Brasile 1.245
DE - Germania 1.124
SE - Svezia 958
VN - Vietnam 836
BG - Bulgaria 546
CA - Canada 412
GB - Regno Unito 410
FR - Francia 380
TR - Turchia 323
RU - Federazione Russa 270
UA - Ucraina 266
FI - Finlandia 253
IN - India 245
KR - Corea 191
AT - Austria 148
JP - Giappone 148
CI - Costa d'Avorio 144
BD - Bangladesh 129
IQ - Iraq 88
CH - Svizzera 69
AR - Argentina 67
NL - Olanda 67
MX - Messico 64
PL - Polonia 58
SN - Senegal 58
ZA - Sudafrica 58
ES - Italia 55
PK - Pakistan 50
VE - Venezuela 46
SA - Arabia Saudita 45
UZ - Uzbekistan 44
ID - Indonesia 39
BE - Belgio 38
EC - Ecuador 33
JO - Giordania 33
MA - Marocco 33
CO - Colombia 31
AU - Australia 30
KE - Kenya 27
EG - Egitto 26
IE - Irlanda 25
JM - Giamaica 24
NG - Nigeria 24
PH - Filippine 21
NP - Nepal 19
AE - Emirati Arabi Uniti 18
CL - Cile 18
CR - Costa Rica 18
DZ - Algeria 18
LT - Lituania 16
MY - Malesia 16
AZ - Azerbaigian 15
PY - Paraguay 15
OM - Oman 14
IL - Israele 13
IR - Iran 13
KZ - Kazakistan 12
TN - Tunisia 12
UY - Uruguay 12
PE - Perù 11
RO - Romania 11
AL - Albania 10
PT - Portogallo 10
CZ - Repubblica Ceca 9
GR - Grecia 9
HN - Honduras 9
BB - Barbados 8
DK - Danimarca 8
KG - Kirghizistan 8
RS - Serbia 8
ET - Etiopia 7
EU - Europa 7
NI - Nicaragua 7
AO - Angola 6
BO - Bolivia 6
DO - Repubblica Dominicana 6
EE - Estonia 6
LK - Sri Lanka 6
TH - Thailandia 6
TT - Trinidad e Tobago 6
AM - Armenia 5
BN - Brunei Darussalam 5
NZ - Nuova Zelanda 5
PA - Panama 5
PS - Palestinian Territory 5
SV - El Salvador 5
BH - Bahrain 4
BY - Bielorussia 4
GE - Georgia 4
GT - Guatemala 4
LB - Libano 4
LV - Lettonia 4
MD - Moldavia 4
QA - Qatar 4
TW - Taiwan 4
Totale 37.614
Salva come PNG Salva come JPEG
Città #
Ashburn 2.053
Singapore 1.755
Woodbridge 1.559
Hong Kong 1.537
Fairfield 1.449
Houston 1.125
San Jose 1.088
Dallas 1.036
Santa Clara 988
Chandler 958
Ann Arbor 813
Seattle 625
Sofia 542
Cambridge 533
Shanghai 531
Beijing 503
Wilmington 500
New York 428
Council Bluffs 427
Milan 354
Los Angeles 327
Boardman 321
Ottawa 277
Hefei 242
Princeton 238
Jacksonville 235
Pisa 234
Florence 224
Lawrence 221
Ho Chi Minh City 213
Lauterbourg 210
Medford 195
Seoul 180
Serra 173
Izmir 172
Hanoi 165
Nanjing 159
Des Moines 147
Abidjan 144
Frankfurt am Main 133
Tokyo 131
Munich 126
Vicopisano 126
São Paulo 123
Buffalo 122
Vienna 117
Istanbul 101
Redondo Beach 99
San Diego 93
Columbus 92
Dearborn 85
London 77
Bremen 67
Rome 67
Boulder 63
Nanchang 62
The Dalles 60
Bern 59
Dakar 58
Dong Ket 58
Ogden 56
Helsinki 54
Chicago 51
Montreal 51
Turku 50
Paris 49
Kunming 47
Pune 45
Warsaw 44
Phoenix 43
Orem 40
Tashkent 40
Nuremberg 39
Jüchen 38
Rio de Janeiro 38
Washington 38
Baghdad 37
Lancaster 37
Brussels 35
Falls Church 35
Toronto 35
Johannesburg 31
Atlanta 30
Da Nang 30
Turin 30
Amman 29
Dhaka 29
Redwood City 29
Tianjin 29
Lucca 28
Shenyang 28
Fuzhou 27
Belo Horizonte 26
Cascina 26
Chennai 26
Nairobi 25
Porto Alegre 25
Haiphong 24
Jiaxing 24
Denver 23
Totale 26.221
Salva come PNG Salva come JPEG
Nome #
Expression status of candidate genes in mesothelioma tissues and cell lines 353
null 346
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people 321
La densità microvascolare (DMV) come marker prognostico e predittivo nelle neoplasie maligne dell'albero bronchiale in fase avanzata. 307
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience 271
Malignant pleural mesothelioma and mesothelial hyperplasia: A new molecular tool for the differential diagnosis 254
SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study 233
Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance 229
Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma 226
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism 223
EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center 219
Percutaneous radiofrequency ablation (pRTA) of pulmonary tumors 218
210P: Digital gene expression profiling to separate malignant pleural mesothelioma from benign reactive mesothelial hyperplasia 216
Distinct Angiogenic microRNA-mRNA Expression Profiles Among Subtypes of Lung Adenocarcinoma. 216
Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features 210
Comparative analysis of genetic variants in pleural fluids and solid tissue biopsies of pleural mesothelioma patients: Implications for molecular heterogeneity assessment 204
Association of the DNMT3B -579G>T polymorphism with risk of thymomas in patients with myasthenia gravis. 203
Second primary lung cancer and relapse: treatment and follow-up. 200
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 199
Surgical treatment of pleural recurrence from thymoma 197
Whole transcriptome targeted gene quantification provides new insights on pulmonary sarcomatoid carcinomas 197
TERMOABLAZIONE DI NEOPLASIE POLMONARI MALIGNE: QUALI PROSPETTIVE 196
Differential microRNA expression profiles between young and old lung adenocarcinoma patients. 196
Screen-detected multiple primary lung cancers in the ITALUNG trial 196
Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study 196
A high vascular count and overexpression of Vascular Endothelial Growth Factor (VEGF) are associated with unfavorable prognosis in operated Small Cell Carcinoma (SCLC) 193
Advanced stage thymomas and thymic carcinomas: results of multimodality treatments 193
A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma 191
Comparison between plasma and serum osteopontin levels: usefulness in diagnosis of epithelial malignant pleural mesothelioma 189
Applications of tissue microarray technology in immunohistochemistry: a study on c-kit expression in small cell lung cancer 187
The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis 187
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 187
ALK rearrangement in a large series of consecutive non-small cell lung cancers: Comparison between a new immunohistochemical approach and fluorescence in situ hybridization for the screening of patients eligible for crizotinib treatment 186
Expression Profiling of LKB1 Pathway in Young and Old Lung Adenocarcinoma Patients. 186
Metachronous adrenal masses in resected non-small cell lung cancer patients:therapeutic implications of laparoscopic adrenalectomy 185
Alterations of Fas (APO-1/CD95) gene and its relationship with p53 in non small cell lung cancer 184
A reappraisal of the indications for laparoscopic treatment of adrenal metastases 183
Resection of single brain metastasis in non-small-cell lung cancer: prognostic factors. 182
2ND PRIMARY LUNG-CANCER AND RELAPSE - TREATMENT AND FOLLOW-UP 181
Four thymus-related syndromes in a case of invasive thymoma 181
Neoangiogenesis and p53 protein in lung cancer: Their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression 181
Neoangiogenesis: A putative marker of malignancy in non-small-cell lung cancer (NSCLC) development 179
A gene-expression-based test can outperform bap1 and p16 analyses in the differential diagnosis of pleural mesothelial proliferations. 179
TNM Staging System in Thymoma: A Critical Appraisal? 178
Pre-operative chemotherapy for stage IIIa (N2) non-small cell lung cancer. 177
Neoangiogenesis as prognostic indicator of survival in lung cancer. 176
KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung 176
CERENKOV LUMINESCENCE IMAGING IN PULMONARY AND HEPATIC METASTASECTOMY 176
Accumulation of gene protein product P53 correlates with high microvessel count in non small cell lung carcinomas 175
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma 174
Surgical treatment of NSCLC in octuagenarians. 172
The multimodality treatment of thymic carcinoma 171
Investigation of MLH1, MGMT, CDKN2A, and RASSF1A Gene Methylation in Thymomas From Patients With Myasthenia Gravis 171
A strategy for thoracoscopic resection of small pulmonary nodules 170
[18F]FDG-PET/CT patterns of bone metastases in lung cancer 169
Chest wall resection for mesothelioma recurrence after surgery 169
Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients 169
Hypertermic Intrathoracic Chemotherapy (HITHOC) for thymoma: a narrative review on indications and results 169
Pleural recurrence of thymoma: Surgical resection followed by hyperthermic intrathoracic perfusion chemotherapy 168
Identification of Fas (APO-1/CD95) and p53 gene mutations in non-small cell lung cancer 167
Intraoperative sentinel lymph node mapping in stage I non-small cell lung cancer: detection of micrometastases by polymerase chain reaction 167
Favourable survival outcome in patients with SCLC treated by sequential intensive chemotherapy and high dose chest irradiation 166
Gene-specific methylation analysis in thymomas of patients with myasthenia gravis 166
Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung 165
Interleukin-8 in non-small cell lung carcinoma: relation with angiogenic pattern and p53 alterations 165
New Keywords in the Treatment of Malignant Pleural Mesothelioma 164
Investigation of GHSR methylation levels in thymomas from patients with Myasthenia Gravis 163
N2 lung cancer is not all the same: an analysis of different prognostic groups 161
Endoscopic thymectomy: A neurologist's perspective 160
Imaging of malignant pleural mesothelioma: It is possible a screening or early diagnosis program? - A systematic review about the use of screening programs in a population of asbestos exposed workers 160
Robotic lobectomy for lung cancer: Evolution in technique and technology 160
Evaluation of the Incidence and Potential Mechanisms of Tracheal Complications in Patients With COVID-19 160
Surgical treatment of non-small cell lung cancer in octogenarians 159
Ten-year experience of mediastinal robotic surgery in a single referral centre 158
WWOX expression in different histologic types and subtypes of non-small cell lung cancer 157
Transcollation® technique in the thoracoscopic treatment of primary spontaneous pneumothorax 157
Acute major airway injuries: clinical features and management 156
Association of thymoma and myasthenia gravis: oncological and neurological results of the surgical treatment 156
MIB1 labelling does not affect metastasis and overall survival in non small cell lung carcinomas 155
Massive pneumoencephalus of late onset after an en-bloc resection for lung cancer 155
Surgical treatment of recurrent thymomas 155
Polymer self-locking clips for vascular control during minimally invasive pulmonary lobectomies 155
Gastropleural fistula as complication of post-pneumonectomy empyema 155
Radio-guided thoracoscopic surgery (RGTS) of small pulmonary nodules. 155
Reply to heyman and van schil 153
Stereotactic body radiation therapy for the treatment of pleural metastases in patients with thymoma: A retrospective review of 22 patients 153
Alterazioni del gene Fas (APO-1/CD95) nei carcinomi polmonari non a piccole cellule (NSCLC). Correlazioni con le alterazioni del gene P53. 151
Percutaneous radiofrequency ablation of primary NSCLC 151
Primary neuroendocrine tumors of the thymus: a multicenter experience of 35 patients. 151
Gamma-probe guided thoracoscopic surgery of small pulmonary nodules 151
Robotic extended thymectomy for early-stage thymomas 151
Role of microRNA-33a in regulating the expression of PD-1 in lung adenocarcinoma. 151
Video robotic lobectomy 150
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors. 150
Liquid biopsies from pleural effusions and plasma from patients with malignant pleural mesothelioma: A feasibility study 150
Thymic carcinoma: a report of 13 cases 149
Nerve-Sparing Surgery in Advanced Stage Thymomas 149
The International Thymic Malignancy Interest Group Classification of Thymoma Recurrence: Survival Analysis and Perspectives 147
Percutaneous radiofrequency ablation of primary NSCLC 146
Differential microRNA Expression Profile between Young and Old Lung Adenocarcinoma Patients. 146
Totale 18.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 115.844
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 115.844
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.637 0 170 97 130 487 371 139 124 165 149 132 673
2022/20233.053 369 375 229 289 307 413 42 219 549 11 221 29
2023/20242.234 199 193 236 269 306 394 120 79 41 40 117 240
2024/20258.504 153 301 74 464 821 758 674 420 916 1.039 956 1.928
2025/20269.910 600 1.152 1.157 839 968 876 1.751 457 588 964 287 271
2026/2027902 264 638 0 0 0 0 0 0 0 0 0 0
Totale 38.180